Related references
Note: Only part of the references are listed.Striatal CB1 and D2 receptors regulate expression of each other, CRIP1A and delta opioid systems
Lawrence C. Blume et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Dopamine D2 receptor-mediated Akt/PKB signalling: initiation by the D2S receptor and role in quinpirole-induced behavioural activation
Han-Ting Chen et al.
ASN NEURO (2012)
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription
R. B. Laprairie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems
Mohammad Reza Zarrindast et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
INVOLVEMENT OF DOPAMINERGIC AND GLUTAMATERGIC SYSTEMS OF THE BASOLATERAL AMYGDALA IN AMNESIA INDUCED BY THE STIMULATION OF DORSAL HIPPOCAMPAL CANNABINOID RECEPTORS
A. Rezayof et al.
NEUROSCIENCE (2011)
The Highs and Lows of Cannabinoid Receptor Expression in Disease: Mechanisms and Their Therapeutic Implications
Lydia K. Miller et al.
PHARMACOLOGICAL REVIEWS (2011)
CB1 Cannabinoid Receptors and their Associated Proteins
Allyn C. Howlett et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Dopaminergic Modulation of Endocannabinoid-Mediated Plasticity at GABAergic Synapses in the Prefrontal Cortex
Chiayu Q. Chiu et al.
JOURNAL OF NEUROSCIENCE (2010)
Ligand-Induced Regulation and Localization of Cannabinoid CB1 and Dopamine D2L Receptor Heterodimers
Julie A. Przybyla et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Striatal Dopamine D2/D3 Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to Impulsivity
Buyean Lee et al.
JOURNAL OF NEUROSCIENCE (2009)
Pharmacological activation of CB1 and D2 receptors in rats:: predominant role of CB1 in the increase of alcohol relapse
Francisco Alen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Regulation of psychostimulant-induced signaling and gene expression in the striatum
Jacqueline F. McGinty et al.
JOURNAL OF NEUROCHEMISTRY (2008)
D2 Dopamine Receptor Activation Facilitates Endocannabinoid-Mediated Long-Term Synaptic Depression of GABAergic Synaptic Transmission in Midbrain Dopamine Neurons via cAMP-Protein Kinase A Signaling
Bin Pan et al.
JOURNAL OF NEUROSCIENCE (2008)
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum
Mauro Maccarrone et al.
NATURE NEUROSCIENCE (2008)
Yin Yang 1 Expression in the Adult Rodent Brain
Marcin Rylski et al.
NEUROCHEMICAL RESEARCH (2008)
Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers.: A combined neurochemical and behavioral analysis
Daniel Marcellino et al.
NEUROPHARMACOLOGY (2008)
Detection of Heteromers Formed by Cannabinoid CB1, Dopamine D-2, and Adenosine A(2A) G-Protein-Coupled Receptors by Combining Bimolecular Fluorescence Complementation and Bioluminescence Energy Transfer
Gemma Navarro et al.
THESCIENTIFICWORLDJOURNAL (2008)
Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes
Christine Boerner et al.
MOLECULAR PHARMACOLOGY (2008)
The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats
Yao-Chang Chiang et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Striatal adenosine A2A and Cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of Cannabinoids
Paulina Carriba et al.
NEUROPSYCHOPHARMACOLOGY (2007)
ERK2:: a logical AND gate critical for drug-induced plasticity?
Jean-Antoine Girault et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
The endocannabinoid pathway in Huntington's disease: A comparison with other neurodegenerative diseases
Mauro Maccarrone et al.
PROGRESS IN NEUROBIOLOGY (2007)
Adenosine A2a blockade prevents synergy between μ-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats
Lina Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Targeting dopamine D2 and Cannabinoid-1 (CB1) receptors in rat nucleus accumbens
VM Pickel et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons
M Andersson et al.
JOURNAL OF NEUROSCIENCE (2005)
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: A mechanism for receptor cross-talk?
CS Kearn et al.
MOLECULAR PHARMACOLOGY (2005)
Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum:: A combined immunochemical and pharmacological analysis
A Köfalvi et al.
JOURNAL OF NEUROSCIENCE (2005)
Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)
FJ Barrero et al.
PHARMACOGENOMICS JOURNAL (2005)
Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum
E Valjent et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Distinct regulation of internalization and mitogen-activated protein kinase activation by two isoforms of the dopamine D2 receptor
SJ Kim et al.
MOLECULAR ENDOCRINOLOGY (2004)
D2 dopamine receptors modulate Gα-subunit coupling of the CB1 cannabinoid receptor
A Jarrahian et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor:: Biochemical and pharmacological characterization
M Rinaldi-Carmona et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal GABAergic transmission
D Centonze et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice
EA McCaw et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors
M Glass et al.
NEUROSCIENCE (2004)
Human cannabinoid receptor 1:: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse
PW Zhang et al.
MOLECULAR PSYCHIATRY (2004)
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-βγ dimers
LN Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion
B Grobben et al.
CELL AND TISSUE RESEARCH (2002)
Mechanism of extracellular signal-regulated kinase activation by the CB1 cannabinoid receptor
I Galve-Roperh et al.
MOLECULAR PHARMACOLOGY (2002)
Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain
YW Lee et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Endocannabinoids and cannabinoid receptor genetics
ES Onaivi et al.
PROGRESS IN NEUROBIOLOGY (2002)
Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain
H Hermann et al.
NEUROSCIENCE (2002)
Δ9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in vivo depends on dopaminergic transmission
E Valjent et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Dopamine receptor regulating factor, DRRF: A zinc finger transcription factor
CK Hwang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum
JP Meschler et al.
NEUROPHARMACOLOGY (2001)
Distinct functions of the two isoforms of dopamine D2 receptors
A Usiello et al.
NATURE (2000)
Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation
I Galve-Roperh et al.
NATURE MEDICINE (2000)
Share Paper
